Christian S. Schade, Chairman & CEO at Aprea Therapeutics, Inc. (APRE), bought 37,500 shares at $0.64 ($24K) on 2022-05-18, disclosed to the SEC on 2022-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IART | SELL | 2018-03-06 | $1.7M | — | Filing → |
| IART | SELL | 2016-05-05 | $1.1M | — | Filing → |
| IART | SELL | 2014-02-28 | $353K | — | Filing → |